Overview
- Argentina’s HPV vaccination coverage has fallen from roughly 80% in 2015 to about 50% by 2024–2025, with experts citing communication and delivery gaps rather than widespread vaccine refusal.
- In Peru, advocates warn the Health Ministry has not approved the 2026 National HPV Vaccination Plan, leaving an operational vacuum and a documented gap of more than 1.6 million unvaccinated 10–18 year‑olds.
- Calls in Peru include a clear timeline to incorporate the nonavalent vaccine and to expand coverage to priority groups defined by law, emphasizing planning to sustain recent gains.
- An international awareness campaign—“What do you do when you don’t know what to do?”—launched on March 4 with ESGO and SEGO backing, aligning with new clinical data on managing persistent infections.
- PALOMA 2 reported higher viral clearance with Papilocare (88% vs 53% at six months), and Argentine hospitals report scaling improved screening with automated HPV genotyping and self‑sampling, processing 3,900 tests with 23% positivity since late 2023.